Security vendors have spent years building up defenses around the endpoint, but one researcher says AI coding tools have ...
Omnissa, a digital work platform company, has released its State of Digital Workspace 2026 report, a global study of ...
CrowdStrike issued a double whammy of releases in time for this week's RSA 2026 event, with new wares focusing on AI agents ...
Despite failing to achieve one of the co-primary endpoints of the SENTRY study, Karyopharm will still approach the FDA for its sNDA.
Omnissa®, a leading digital work platform company, today released its State of Digital Workspace 2026 report, a global study ...
NowSecure customer data is not included in the ADP dataset. The company maintains strict separation between customer testing ...
Karyopharm Therapeutics said its treatment for myelofibrosis, a rare blood cancer, met one of its co-primary endpoints in a recent late-stage trial, but missed the other. The pharmaceutical company ...
Shares of Karyopharm Therapeutics declined after the pharmaceutical company said its treatment for myelofibrosis, a rare blood cancer, missed one of the primary endpoints in a recent late-stage trial.
In December 2025, the Company reported that sunRIZE demonstrated reductions from baseline in hypoglycemia events, but the study did not meet its primary endpoint because the reductions were not ...
Poor patch management, increasingly complex IT environments and continued use of obsolete software puts organizations at risk ...
What it is. AXPAXLI (OTX-TKI) is an investigational, bioresorbable intravitreal hydrogel implant designed to continuously ...
CrowdStrike launches Agentic MDR, Falcon Data Security & Cloud upgrades to stop AI-powered cyberattacks rising 89% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results